158 related articles for article (PubMed ID: 22051530)
21. [A management program for primary thrombocytopenia].
Knutsen H; Bruserud O
Tidsskr Nor Laegeforen; 1999 Sep; 119(23):3431-4. PubMed ID: 10553341
[TBL] [Abstract][Full Text] [Related]
22. Management of essential thrombocythemia.
Cervantes F
Hematology Am Soc Hematol Educ Program; 2011; 2011():215-21. PubMed ID: 22160037
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment.
Haznedaroglu IC
Expert Opin Pharmacother; 2013 Aug; 14(11):1431-6. PubMed ID: 23647225
[TBL] [Abstract][Full Text] [Related]
24. Expertise-based management in essential thrombocythemia and polycythemia vera.
Finazzi G; Barbui T
Cancer J; 2007; 13(6):372-6. PubMed ID: 18032974
[TBL] [Abstract][Full Text] [Related]
25. Management of the myeloproliferative disorders : distinguishing data from dogma.
Green AR; Vassiliou GS; Curtin N; Campbell PJ
Hematol J; 2004; 5 Suppl 3():S126-32. PubMed ID: 15190294
[No Abstract] [Full Text] [Related]
26. Current treatment practice for essential thrombocythaemia in adults.
Griesshammer M; Bangerter M; Grünewald M
Expert Opin Pharmacother; 2001 Mar; 2(3):385-93. PubMed ID: 11336593
[TBL] [Abstract][Full Text] [Related]
27. Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review.
Martinelli P; Martinelli V; Agangi A; Maruotti GM; Paladini D; Ciancia R; Rotoli B
Am J Obstet Gynecol; 2004 Dec; 191(6):2016-20. PubMed ID: 15592285
[TBL] [Abstract][Full Text] [Related]
28. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
29. Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations.
Tefferi A; Passamonti F
Am J Hematol; 2009 Oct; 84(10):629-30. PubMed ID: 19731306
[No Abstract] [Full Text] [Related]
30. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
31. Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.
Kiladjian JJ; Rain JD; Bernard JF; Briere J; Chomienne C; Fenaux P
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):417-21. PubMed ID: 16810617
[TBL] [Abstract][Full Text] [Related]
32. Essential thrombocythaemia in children: is a treatment needed?
Randi ML; Putti MC
Expert Opin Pharmacother; 2004 May; 5(5):1009-14. PubMed ID: 15155103
[TBL] [Abstract][Full Text] [Related]
33. Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia.
Doubek M; Brychtova Y; Doubek R; Janku P; Mayer J
Ann Hematol; 2004 Nov; 83(11):726-7. PubMed ID: 15278298
[No Abstract] [Full Text] [Related]
34. When and how to treat essential thrombocythemia.
Barbui T; Finazzi G
N Engl J Med; 2005 Jul; 353(1):85-6. PubMed ID: 16000360
[No Abstract] [Full Text] [Related]
35. Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review.
Sobas MA; Pérez Encinas MM; Rabuñal Martinez MJ; Quinteiro García C; Bello López JL
Acta Haematol; 2009; 122(4):221-2. PubMed ID: 19887779
[No Abstract] [Full Text] [Related]
36. Interferon α-2b gains high sustained response therapy for advanced essential thrombocythemia and polycythemia vera with JAK2V617F positive mutation.
Huang BT; Zeng QC; Zhao WH; Li BS; Chen RL
Leuk Res; 2014 Oct; 38(10):1177-83. PubMed ID: 25069759
[TBL] [Abstract][Full Text] [Related]
37. Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.
Schrickel L; Heidel FH; Sadjadian P; Becker T; Kolatzki V; Hochhaus A; Griesshammer M; Wille K;
J Cancer Res Clin Oncol; 2021 May; 147(5):1481-1491. PubMed ID: 33140210
[TBL] [Abstract][Full Text] [Related]
38. Essential thrombocythaemia treatment options: addressing patient-specific needs.
Birgegård G
Eur J Haematol Suppl; 2007 Oct; (68):27-31. PubMed ID: 17727563
[No Abstract] [Full Text] [Related]
39. [Management of patients with essential thrombocythemia].
Ramirez G; García-Sanchez R; Plaza S
Med Clin (Barc); 2013 Mar; 140(6):278-82. PubMed ID: 23177312
[No Abstract] [Full Text] [Related]
40. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
Neikova K ; Dimitrova V; Dimitrov R; Savov A
Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
